Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
Danaher Q2: Inventory Overhang, But Low Expectations Limit Downside
10:32am, Friday, 19'th Jul 2024
Danaher Corporation stock saw a high single-digit percentage increase from April to mid-June, but has since given up most of the gains. Concerns about inventory destocking in the bioprocessing market
Danaher (DHR) Gears Up to Post Q2 Earnings: What to Expect
11:21am, Thursday, 18'th Jul 2024
Danaher's (DHR) second-quarter earnings are likely to be aided by strength in the Diagnostics and Life Sciences segment.
Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development
07:30am, Wednesday, 17'th Jul 2024
DH Diagnostics LLC Centers aim to accelerate drug development by speeding and streamlining development and commercialization of companion diagnostics. Clinical Laboratory Improvement Amendments (CLIA)
Danaher (DHR) Upgraded to Buy: Here's What You Should Know
01:05pm, Tuesday, 16'th Jul 2024
Danaher (DHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Is Danaher (DHR) Stock Outpacing Its Conglomerates Peers This Year?
10:41am, Tuesday, 16'th Jul 2024
Here is how Danaher (DHR) and Honeywell International Inc. (HON) have performed compared to their sector so far this year.
Danaher Releases 2024 Sustainability Report
07:30am, Tuesday, 16'th Jul 2024
WASHINGTON , July 16, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), the global life sciences and diagnostics innovator, today published its 2024 Sustainability Rep
Predictive tools will seek to reduce leading cause of failure rates in clinical trials of oncology drugs. Integrated AI and microscopy expected to lead to better understanding of tumor structures and
Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer
03:00am, Tuesday, 09'th Jul 2024
Ideally Suited for Satellite and Independent Labs, the new DxC 500i Analyzer Offers Flexibility, Scalability and Data Commutability with Extensive Chemistry and Immunoassay Assay Menu The New DxC 500i
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
11:03am, Friday, 28'th Jun 2024
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention.
Danaher Schedules Second Quarter 2024 Earnings Conference Call
04:30pm, Monday, 24'th Jun 2024
WASHINGTON , June 24, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2024 on Tuesday, July 23, 2024
Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics
07:30am, Wednesday, 19'th Jun 2024
WASHINGTON , June 19, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), a leading global life sciences and diagnostics innovator, today announced that Julie Sawyer Mon
Dublin, June 19, 2024 (GLOBE NEWSWIRE) -- The "Global Flow Cytometry Market by Technology (Cell-based, Bead-Based), Product & Service (Analyzer, Sorter, Consumables (Antibodies, Assays, Kits), Softwar
Here's Why Hold Strategy Is Apt for Danaher (DHR) Stock Now
11:01am, Friday, 14'th Jun 2024
Strength in the Life Sciences segment augurs well for Danaher (DHR). The company's measures to reward its shareholders are promising.
Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence Officer
07:00am, Wednesday, 05'th Jun 2024
Move reflects increasing investment in AI as driving force for innovation and productivity. Company will host Innovation Summit in December focused on AI in R&D.
Why Is Danaher (DHR) Up 6.7% Since Last Earnings Report?
12:36pm, Thursday, 23'rd May 2024
Danaher (DHR) reported earnings 30 days ago. What's next for the stock?
